Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Uremic toxin metabolism refers to the production, transformation, and elimination of a diverse group of endogenous metabolites that accumulate in the body when renal function declines. These toxins contribute to the clinical syndrome of uremia, exerting direct toxicity on multiple organ systems and promoting inflammation, oxidative stress, and vascular calcification. Therapeutic strategies target enhancing clearance, reducing production, or mitigating downstream toxic effects.
Varied; depends on the specific strategy: Enhanced toxin removal by dialysis/adsorption; Reduced toxin production by altering diet/gut microbiota; Inhibition of toxin signaling pathways (e.g., AhR)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Uremic Toxin Metabolism.